Answers from the Lab cover art

All Episodes

Answers from the Lab — 381 episodes

#
Title
1

Lab Stewardship in Modern Healthcare

2

Unique Assays Advance Care of Complex Autoimmune Skin Conditions

3

Digital Advances: What’s Next for Clinical Diagnostics?

4

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes

5

Breakthrough Test Enhances Peripheral Neuropathy Care and Research

6

How Strategic Collaborations Transform Clinical Diagnostics

7

Innovation and Resilience in Lab Logistics

8

2026 Forecast: Trends Shaping the Future of Diagnostics

9

Speed Without Sacrifice: How Diagnostics Can Move Quickly and Safely

10

Breakthroughs and Trends That Defined Lab Medicine in 2025

11

Accelerating Research and Development With BioPharma Diagnostics

12

Unlocking the Unknown With Metagenomics

13

Forging Collaborations That Deliver Better Outcomes

14

Advancing Precision Medicine Through Therapeutic Tests

15

Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.

16

Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.

17

Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.

18

Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC

19

Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.

20

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

21

New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D.

22

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.

23

Expanded assay better identifies hereditary pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

24

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.

25

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

26

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

27

Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S

28

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

29

Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D.

30

Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D.

31

Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.

32

Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.

33

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.

34

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

35

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

36

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

37

The Emergence of Retail Health: Bill Morice, M.D., Ph.D.

38

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.

39

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

40

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

41

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

42

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

43

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

44

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

45

The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.

46

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.

47

Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.

48

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.

49

Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC

50

Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.

51

What’s Causing Outbreaks of Preventable Infectious Diseases: Bill Morice, M.D., Ph.D.

52

Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D.

53

Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC

54

Navigating Technology Disruptions: John Osborn

55

Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.

56

The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D.

57

Overcoming Health Threats Through Public-Private Lab Partnerships: Bill Morice, M.D., Ph.D.

58

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

59

Advancing Lupus Treatment With Modern Diagnostics: Bill Morice, M.D., Ph.D.

60

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

61

Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D.

62

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

63

Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D.

64

Trends in the Laboratory and Diagnostic Testing Market: Bill Morice, M.D., Ph.D.

65

Why Mpox is a Public Health Emergency: Matthew Binnicker, Ph.D.

66

Tracking the Latest Pathogens: Bill Morice, M.D., Ph.D.

67

Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

68

Global Industry Activities: Bill Morice, M.D., Ph.D.

69

Alarming Increase in Dengue Cases: Elitza Theel, Ph.D.

70

Scaling Knowledge With AI: Bill Morice, M.D., Ph.D.

71

An Impactful Supreme Court Decision: Bill Morice, M.D., Ph.D.

72

The Metals Laboratory Tests Beethoven’s Hair: Paul Jannetto, Ph.D.

73

COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D.

74

The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D.

75

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

76

Infectious Diseases on the Move: Bill Morice, M.D., Ph.D.

77

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S.

78

Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D.

79

Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D.

80

Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S.

81

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.

82

Get to Know the DLMP Chair: Eric Hsi, M.D.

83

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

84

FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

85

The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D.

86

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

87

Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.

88

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D

89

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

90

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

91

Tick Season Outlook: Elitza Theel, Ph.D.

92

Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.

93

Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.

94

Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

95

Why Measles Is on the Rise: Matthew Binnicker, Ph.D.

96

Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

97

Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.

98

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

99

Syphilis Testing Updates: Elitza Theel, Ph.D.

100

Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.

101

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.

102

Black History Month: Bill Morice, M.D., Ph.D.

103

Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.

104

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.

105

Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.

106

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.

107

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

108

The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.

109

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.

110

Evolution of Syphilis: Elitza Theel, Ph.D.

111

A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.

112

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

113

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.

114

Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC

115

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.

116

The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.

117

Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.

118

Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

119

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.

120

Comments on the FDA’s Proposed Rule: Bill Morice, M.D., Ph.D.

121

Protecting Against Winter Respiratory Viruses: Bill Morice, M.D., Ph.D.

122

Congressional and Federal Updates: Bill Morice, M.D., Ph.D.

123

Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D.

124

RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.

125

Safeguards for AI in Healthcare: Bill Morice, M.D., Ph.D.

126

A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

127

Opportunities Around At-Home Testing: Bill Morice, M.D., Ph.D.

128

How AI Can Add Value to Laboratory Medicine: Bill Morice, M.D., Ph.D.

129

Transformative Technologies: Bill Morice, M.D., Ph.D.

130

Proposed Regulations for Laboratory Developed Tests: Bill Morice, M.D., Ph.D.

131

Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D.

132

Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D.

133

What to Know About Leprosy: Nancy Wengenack, Ph.D.

134

Flea-borne Typhus: Elitza Theel, Ph.D.

135

Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D.

136

Summertime Pathogens: Bill Morice, M.D., Ph.D.

137

Modern-day Outbreaks: Bill Morice, M.D., Ph.D.

138

Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D.

139

Learning Through Teaching Global Health: Bill Morice, M.D., Ph.D.

140

Panel pinpoints causes of genetic hearing loss: Nicole Boczek, Ph.D., and Melanie Meyer, M.S, CGC

141

Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D.

142

Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

143

Dengue and Chikungunya Outbreaks: Elitza Theel, Ph.D.

144

Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

145

Malaria in the United States: Bill Morice, M.D., Ph.D.

146

Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

147

The Latest on Measles: Matthew Binnicker, Ph.D.

148

Results report simplifies urine test interpretation: John Lieske, M.D.

149

FDA Oversight of Lab-Developed Tests: Bill Morice, M.D., Ph.D.

150

Multigene panel provides efficient ataxia diagnosis: Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC

151

Remote Diagnostics: Bill Morice, M.D., Ph.D.

152

Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D.

153

Diagnosing Lyme Disease: Bill Morice, M.D., Ph.D.

154

BioPharma Diagnostics: Bill Morice, M.D., Ph.D.

155

The impact of AI: Bill Morice, M.D., Ph.D.

156

West Nile virus: Elitza Theel, Ph.D.

157

The progression of the diagnostic landscape: Bill Morice, M.D., Ph.D.

158

Endemic fungal infections in North America: Elitza Theel, Ph.D.

159

A strong community of lab professionals: Bill Morice, M.D., Ph.D., and Susan Van Meter

160

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D.

161

Emerging fungal pathogens: Dr. Nancy Wengenack

162

Leading important industry conversations: Bill Morice, M.D., Ph.D.

163

IDH assay facilitates timelier leukemia treatment: Rong He, M.D.

164

Neurofilament light chain: Bjorn Oskarsson, M.D.

165

Approaching tick season: Bill Morice, M.D., Ph.D.

166

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D.

167

Avian influenza and reflecting on three years of COVID-19: Matthew Binnicker, Ph.D.

168

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D.

169

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D.

170

Amplifying the voice of the lab during policymaking: Dr. Bill Morice

171

Whole genome sequencing streamlines diagnosis: Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC

172

Rising rates of group A streptococcus and antibiotic resistant gonorrhea: Dr. Robin Patel

173

Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.

174

When to test for norovirus: Dr. Bill Morice

175

THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.

176

Sharing Mayo Clinic knowledge globally while learning from other cultures: Dr. Bill Morice

177

Novel biomarkers added to movement disorders profile: Andrew McKeon, M.B., B.Ch., M.D.

178

How digital pathology is changing patient care at Mayo Clinic: Dr. Joaquin Garcia

179

New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.

180

Triple-demic update and the future of at-home testing: Dr. Bill Morice

181

Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice

182

Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

183

Legislative update and at-home testing: Dr. Bill Morice

184

Why cancer death rates are declining: Dr. Ansell

185

Respiratory virus update and a new measles test: Dr. Matthew Binnicker

186

Predictions for 2023: Dr. Bill Morice

187

The laboratory’s role in spurring innovation: Dr. Bill Morice

188

Respiratory illness updates and health care economics: Dr. Bill Morice

189

Ensuring quality in the lab: Dr. Bill Morice

190

Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.

191

Staying safe during the holidays: Dr. Bill Morice

192

Carrier Screening: Linda Hasadsri, M.D., Ph.D.

193

The challenges facing most health care leaders: Dr. Bill Morice

194

Novel malabsorption panel speeds diagnosis: Puanani Hopson, D.O.

195

Legislation, leadership, and MayoComplete: Dr. Bill Morice

196

Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

197

Testing is essential in the months ahead: Dr. Bill Morice

198

Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

199

Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.

200

Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

201

Unique pediatric evaluation targets relevant autoimmune/CNS antibodies: Andrew McKeon, M.B., B.Ch., M.D.

202

Preparing for respiratory infection season: Dr. Matthew Binnicker

203

Chain of Custody Testing: Loralie Langman, Ph.D.

204

Shifting from pandemic to endemic: Dr. Bill Morice

205

Virus outlook heading into fall: Dr. Bill Morice

206

Advocating for lab legislation: Dr. Bill Morice

207

PIK3CA assay guides treatment of progressing breast cancer: Katherine Geiersbach, M.D.

208

Leading diagnostics into the future: Dr. Bill Morice

209

PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.

210

PETH: Paul Jannetto, Ph.D.

211

Looking at the big picture: Dr. Bill Morice

212

Precision therapeutics can individualize depression treatment: Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D.

213

State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC

214

Monkeypox and legislation updates: Dr. Bill Morice

215

CIDP: Divyanshu (Div) Dubey, M.B.B.S.

216

Ongoing evolution of monkeypox: Dr. Bill Morice

217

PMND1: John Lieske, M.D.

218

Monkeypox testing progress: Dr. Bill Morice

219

Enhanced detection of genetic mutation to optimize leukemia treatment: Rong He, M.D.

220

Operationalizing monkeypox testing: John Osborn

221

Nonradioactive assay helps diagnose heparin reaction: Rajiv Pruthi, M.B.B.S.

222

Monkeypox declared a global public health emergency: Dr. Bill Morice

223

FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.

224

Managing the current rise in COVID cases: Dr. Bill Morice

225

Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice

226

New SALSA bill and monkeypox testing at Mayo: Dr. Bill Morice

227

The Latest on Monkeypox and Lab Legislation: Dr. Bill Morice

228

The age of pandemics: Dr. Bill Morice

229

WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC

230

Monkeypox: Dr. Bill Morice

231

Being Mindful of Mental Health: John Black, M.D.

232

Viruses and variants: Dr. Bill Morice

233

Recent Outbreaks of Viral Infections: Dr. Matt Binnicker

234

VALID Act: Dr. Bill Morice

235

Tick-borne Disease Testing: Elitza Theel, Ph.D.

236

Lab Legislation Update: Dr. Bill Morice

237

NFLC: Alicia Algeciras, Ph.D.

238

Lab Medicine’s Role in the Clinical Practice: Dr. Bill Morice

239

ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.

240

Regulation of Lab Developed Tests: Dr. Bill Morice

241

Advancements in autoimmune neurology: Dr. Andrew McKeon

242

COVID-19 Update: Dr. Bill Morice

243

IBDP2: Melissa Snyder, Ph.D.

244

CLIA-Licensed Laboratories: Dr. Bill Morice

245

Chromium and Cobalt: Paul Jannetto, Ph.D.

246

Laboratory Innovation: Dr. Bill Morice

247

TPNUQ: Ann Moyer, M.D., Ph.D.

248

Lab developed tests: Dr. Bill Morice

249

MSP3: Maria Alice Willrich, Ph.D.

250

New COVID-19 variants: Dr. Bill Morice

251

Oversight of the laboratory industry: Dr. Bill Morice

252

Urinary ammonium testing: John Lieske, M.D.

253

New Strategies to Combat COVID-19: Dr. Bill Morice

254

New Masking Guidelines: Dr. Bill Morice

255

Extended spectrum beta lactamase testing: Audrey Schuetz, M.D.

256

Informatics and Laboratory Medicine: Dr. David McClintock

257

Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.

258

Adapting as COVID-19 Changes: Dr. Bill Morice

259

Interpreting Lab Test Results: Dr. Bill Morice

260

Tackling COVID-19 Misinformation: Dr. Bill Morice

261

A Global Perspective on COVID-19: Dr. Bill Morice

262

COVID-19 Antigen Tests: Dr. Bill Morice

263

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.

264

Respiratory Virus Testing: Dr. Matthew Binnicker

265

Omicron Update: Dr. Bill Morice

266

Reflections on how far we’ve come: Dr. Bill Morice

267

Autoimmune Axonal Testing: Divyanshu (Div) Dubey, M.B.B.S.

268

At-Home COVID-19 Tests: Dr. Brad Karon

269

Holiday Safety and COVID-19: Dr. Bill Morice

270

The State of COVID-19 Now: Dr. Bill Morice

271

Omicron Variant: Dr. Bill Morice

272

CYPZ: Michelle Kluge, M.S., CGC

273

Lab-Developed Tests: Shannon Bennett

274

Hereditary Oncology Testing: Wei Shen, Ph.D.

275

COVID-19 Antibody Testing: Dr. Elitza Theel

276

IDENT: Audrey Schuetz, M.D.

277

COVID-19, Moving Forward: Dr. Bill Morice

278

The State of COVID-19 Today: Dr. Bill Morice

279

The Global Impact of COVID-19: Dr. Bill Morice

280

NF155: John Mills, Ph.D.

281

How AI is Shaping the Future of Laboratory Medicine: Dr. Bill Morice

282

Mitochondrial disease: Linda Hasadsri, M.D., Ph.D.

283

The Value of a Flu Vaccine Amid COVID-19: Dr. Bill Morice

284

T-cell Lymphoma Testing: Dr. Andrew Feldman

285

COVID-19 National Strategy: Dr. Bill Morice

286

PGXQP: Ann Moyer, M.D., Ph.D.

287

COVID-19 Vaccine Myths: Dr. Bill Morice & Dr. Matt Binnicker

288

COVID-19 Vaccine Boosters: Dr. Bill Morice

289

Candida Auris: Dr. Nancy Wengenack

290

COVID-19 Breakthrough Infections: Dr. Bill Morice

291

COVID-19 Update: Dr. Bill Morice

292

MAG Antibody Testing: John Mills, Ph.D.

293

COVID-19 Surge: Dr. Bill Morice

294

Coronavirus Delta Variant: Dr. Bill Morice

295

Vector-Borne Diseases: Dr. Bobbi Pritt & Dr. Bill Morice

296

Disaccharidase Activity Panel: Puanani (Pua) E. Hopson, D.O.

297

Lab fee reimbursement: Dr. Bill Morice

298

Kelch-11: Divyanshu (Div) Dubey, M.B.B.S.

299

The Current State of COVID-19: Dr. Bill Morice

300

NELL-1: Sanjeev Sethi, M.D., Ph.D.

301

Leading in Laboratory Medicine: Dr. Bill Morice

302

West Nile virus PCR testing: Bobbi Pritt, M.D.

303

MayoComplete Solid Tumor Panel: Kevin C. Halling, M.D., Ph.D.

304

Mayo Clinic, Thermo Fisher Collaboration: Dr. Bill Morice

305

Laboratory Medicine After COVID-19: Dr. Bill Morice

306

TMA: Meera Sridharan, M.D., Ph.D.

307

Mayo Clinic Laboratories: Dr. Bill Morice

308

Lab Innovation During COVID-19: Dr. Bill Morice

309

Autoimmune Profile Updates: Andrew McKeon, M.B., B.Ch., M.D.

310

COVID-19 Vaccine Safety: Dr. Bill Morice

311

COVID-19 Testing Update: Joseph Yao, M.D.

312

Vaccine Passports: Dr. Bill Morice

313

Myasthenia Gravis: Christopher Klein, M.D.

314

COVID-19 Vaccine Update: Dr. Bill Morice

315

COVID-19 Vaccine Hesitancy: Dr. Bill Morice

316

The Path to Leadership: Dr. Bill Morice

317

Female Leadership at Mayo Clinic: Dr. Bill Morice

318

The Future of Lab Medicine Beyond COVID-19: Dr. Bill Morice

319

How COVID-19 Changed the Future of Lab Medicine: Dr. Bill Morice

320

Paraneoplastic Vision Loss Evaluation: Andrew McKeon, M,B., B.Ch., M.D.

321

The Impact of COVID-19 Variants: Dr. Matthew Binnicker

322

MASS-FIX: David Murray, M.D., Ph.D.

323

National COVID-19 Strategy: Dr. Bill Morice

324

Debunking COVID-19 Vaccine Myths: Dr. Bill Morice

325

Pancreatic Elastase Test: Puanani Hopson, D.O.

326

Laboratory Medicine in 2021 and Beyond: Dr. Bill Morice

327

COVID-19 Variants: Dr. Bill Morice

328

2020 COVID-19 Recap: Dr. Bill Morice

329

Dendritic Cell Enumeration Test: Amir Sadighi Akha, M.D., D.Phil.

330

Soaring Interest in Health Care Professions: Dr. Bill Morice

331

Updated Testing Algorithms for Plasma Cell Proliferative Disorders: Xinjie Xu, Ph.D.

332

Debunking Mask Myths: Dr. Bill Morice

333

Paraffin-Embedded Tissue Testing for COVID-19: Anja Roden, M.D.

334

Masks and COVID-19 Prevention: Dr. Bill Morice

335

Hereditary Hearing Loss: Nicole Boczek, Ph.D.

336

COVID-19 Vaccine Update: Dr. Bill Morice

337

COVID-19 Antibody Testing Update: Elitza Theel, Ph.D.

338

Treatment for COVID-19: Dr. Bill Morice

339

Alpha-Gal Testing: Joshua Bornhorst, Ph.D.

340

COVID-19 and Herd Immunity: Dr. Bill Morice

341

Distinguishing COVID-19 From Other Respiratory Illnesses: Aaron Tande, M.D.

342

COVID-19 Testing 101: Dr. Bill Morice

343

B-Cell Lymphoblastic Leukemia Monitoring for Minimal Residual Disease: Min Shi, M.D., Ph.D.

344

Enjoying Fall Activities Safely During COVID-19: Dr. Bill Morice

345

Coagulopathies and COVID-19: Nahla Heikal, M.D.

346

Staying Safe Amid a Surge in COVID-19: Dr. Bill Morice

347

MDM2 Gene Amplification: William Sukov, M.D.

348

Behind the Scenes in a Processing Lab During COVID-19: Jonathan Berry

349

COVID-19 – At-Home Sample Collection vs. At-Home Testing: Dr. Bill Morice

350

COVID Testing at Home: Dr. Bill Morice

351

Different Forms of Masking: Dr. Bill Morice

352

Quality Management during COVID-19: Jill Hill

353

Screening and Surveillance Testing: Dr. Bill Morice

354

Labor Day Weekend Precautions: Dr. Bill Morice

355

Laboratory Perspective of COVID-19: Aimee Boerger and Emily Fernholz

356

Leadership in a Time of Uncertainty: Dr. Bill Morice

357

Maximizing Testing Capacity: Dr. Bill Morice

358

Herd Immunity: Dr. Bill Morice

359

600th Case of the Week on Creepy Dreadful Wonderful Parasites: Dr. Bobbi Pritt

360

Pooling and Precautions: Dr. Bill Morice

361

Benefits of Wearing a Mask: Dr. Bill Morice

362

Supply Chain Management during COVID-19: Dr. Paul Jannetto

363

Delta Air Lines Partnership: Dr. Bill Morice

364

Neutralizing Antibody Assay, Explained: Dr. John Mills

365

Future of COVID-19 Laboratory Testing: Dr. Bill Morice

366

New COVID-19 Test Launch and Employee Testing: Dr. Bill Morice

367

Serology Testing for COVID-19: Dr. Elitza Theel

368

Innovation in COVID-19 Testing: Dr. Bill Morice

369

Using COVID-19 Testing to Help Restart the Economy: Dr. Bill Morice

370

Microbiology Leadership during the COVID-19 Pandemic: Dr. Robin Patel

371

Evolution of the COVID-19 Pandemic: Dr. Bill Morice

372

Podcasting Discussion with the Bow Tie Bandit of Blood: Dr. Justin Kreuter

373

State-Level Testing for COVID-19: Dr. Bill Morice

374

Increased PCR Testing Capacity for COVID-19: Dr. Joseph Yao

375

Leadership and Collaboration During COVID-19: Dr. Bill Morice

376

Drive-up Phlebotomy Services for Serology Testing: Nicole Kang

377

Minnesota Partnership for COVID-19 Pandemic: Dr. Bill Morice

378

Understanding COVID-19 Testing Options: Dr. Matt Binnicker

379

Leadership during the COVID-19 Pandemic: Dr. Bill Morice

380

Serology Testing for COVID-19: Dr. Elitza Theel

381

Coming Soon: Answers from the Lab Podcast